Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.

A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a ...

Genenta Science shares surged by more than double Friday after the company said it has partnered with Anemocyte to collaborate on its plasmid DNA technology platform. The stock was briefly halted from ...

A 2007 home invasion and sexual assault case was solved nearly 20 years later using advanced DNA genealogy, authorities say.

When it comes to treating disease, one promising avenue is addressing the presence of senescent cells. These cells—also known ...

Researchers developed an experimental method to convert skin cells into eggs, potentially allowing older women and same-sex ...

A judge denied bail for a man who investigators say broke into a woman’s home in 2007, tied her up and sexually assaulted her ...

New sonar footage from Loch Ness has revived the legend of 'Nessie,' but scientists say advanced technology has yet to prove ...

Ancient DNA from Napoleon’s soldiers reveals enteric and relapsing fevers - not typhus - as key killers during the army’s ...

Scholars have debated precisely what kinds of diseases ravaged Napoleon’s troops. New DNA analysis of some soldiers’ remains ...